Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its initial stages.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...

With a federal OK in hand, GE HealthCare says it sees promise in the field of Alzheimer's disease detection and treatment. The Chicago-based imaging and device giant announced Sept. 17 it received ...

Determining the specific type of dementia early in the diagnostic process can lead to more targeted treatments and better outcomes ...

Two new drugs for Alzheimer’s have been rejected for use on the NHS. They slow progression of the disease, but they can have ...

With Alzheimer’s disease, parts of the brain responsible for memory, understanding, language, attention, reasoning, and judgment become damaged. In Alzheimer’s, brain cells build up a toxic ...

The Alzheimer’s Association reports that 50-70% of symptomatic patients in community settings are inaccurately diagnosed with Alzheimer’s disease. In specialized memory clinics, this ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in the brain.

Anti-amyloid medications work inside the brain to prevent Alzheimer’s disease from progressing. While this field is still relatively new, the prospects are exciting.

A blood test that can help diagnose Alzheimer’s disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to ...

Alzheimer's disease plagues South Carolina, with more than 112,00 patients and a high death rate. New blood test analyzers at MUSC could speed up diagnosis.